Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Comment to the reply letter: re Walter et al.'s letter to the editor.

Walter SD, Macaskill P, Turner R, Guyatt G, Cook R, Prasad K.

Stat Methods Med Res. 2018 Jan 1:962280218768107. doi: 10.1177/0962280218768107. [Epub ahead of print] No abstract available.

PMID:
29633654
2.

Letter to the Editor: re Heo et al. (SMMR, November 9 2017).

Walter SD, Macaskill P, Turner R, Guyatt G, Cook R, Prasad K.

Stat Methods Med Res. 2018 Jan 1:962280218767691. doi: 10.1177/0962280218767691. [Epub ahead of print] No abstract available.

PMID:
29633629
3.

Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.

Caumo F, Romanucci G, Hunter K, Zorzi M, Brunelli S, Macaskill P, Houssami N.

Breast Cancer Res Treat. 2018 Jul;170(2):391-397. doi: 10.1007/s10549-018-4756-4. Epub 2018 Mar 20.

PMID:
29557996
4.

Standard deviation and standard error: interpretation, usage and reporting.

Macaskill P.

Med J Aust. 2018 Feb 5;208(2):63-64. No abstract available.

PMID:
29385971
5.

Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.

McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; the PRISMA-DTA Group, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP, Stevens A, Takwoingi Y, Tonelli M, Weeks L, Whiting P, Willis BH.

JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163.

PMID:
29362800
6.

Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.

Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, Romanucci G, Gentilini MA, Zorzi M, Macaskill P.

Breast. 2018 Apr;38:150-153. doi: 10.1016/j.breast.2018.01.002. Epub 2018 Jan 9.

PMID:
29328943
7.

Serum lactate cut-offs as a risk stratification tool for in-hospital adverse outcomes in emergency department patients screened for suspected sepsis.

Shetty AL, Thompson K, Byth K, Macaskill P, Green M, Fullick M, Lander H, Iredell J.

BMJ Open. 2018 Jan 5;8(1):e015492. doi: 10.1136/bmjopen-2016-015492.

8.

Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis.

Mahady SE, Macaskill P, Craig JC, Wong GLH, Chu WCW, Chan HLY, George J, Wong VWS.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1453-1460.e1. doi: 10.1016/j.cgh.2017.02.031. Epub 2017 Mar 7.

PMID:
28286195
9.

Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice.

Walter SD, Turner RM, Macaskill P, McCaffery KJ, Irwig L.

BMC Med Res Methodol. 2017 Feb 20;17(1):29. doi: 10.1186/s12874-017-0304-x.

10.

Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial.

Houssami N, Bernardi D, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Macaskill P.

Cancer Epidemiol. 2017 Apr;47:94-99. doi: 10.1016/j.canep.2017.01.008. Epub 2017 Feb 11.

PMID:
28192742
11.

Predicting recovery in patients with acute low back pain: A Clinical Prediction Model.

da Silva T, Macaskill P, Mills K, Maher C, Williams C, Lin C, Hancock MJ.

Eur J Pain. 2017 Apr;21(4):716-726. doi: 10.1002/ejp.976. Epub 2017 Jan 20.

PMID:
28107604
12.

Diagnostic accuracy of the Ottawa Ankle and Midfoot Rules: a systematic review with meta-analysis.

Beckenkamp PR, Lin CC, Macaskill P, Michaleff ZA, Maher CG, Moseley AM.

Br J Sports Med. 2017 Mar;51(6):504-510. doi: 10.1136/bjsports-2016-096858. Epub 2016 Nov 24. Review.

PMID:
27884861
13.

Obesity and hypertension in Australian young people: results from the Australian Health Survey 2011-2012.

Kim S, Lewis JR, Baur LA, Macaskill P, Craig JC.

Intern Med J. 2017 Feb;47(2):162-169. doi: 10.1111/imj.13298.

PMID:
27761992
14.

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ, Houssami N.

Ann Surg Oncol. 2016 Nov;23(12):3811-3821. Epub 2016 Aug 15. Review.

15.

Elevated Liver Enzymes and Mortality in Older Individuals: A Prospective Cohort Study.

Mahady SE, Wong G, Turner RM, Mitchell P, Macaskill P, Craig JC, George J.

J Clin Gastroenterol. 2016 Jul 29. [Epub ahead of print]

PMID:
27479143
16.

Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.

Bernardi D, Macaskill P, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Houssami N.

Lancet Oncol. 2016 Aug;17(8):1105-1113. doi: 10.1016/S1470-2045(16)30101-2. Epub 2016 Jun 23.

PMID:
27345635
17.

Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents.

Kim S, Macaskill P, Hodson EM, Daylight J, Williams R, Kearns R, Vukasin N, Lyle DM, Craig JC.

Pediatr Nephrol. 2017 Jan;32(1):119-129. Epub 2016 Jun 23.

PMID:
27338727
18.

Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.

Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto Y, Kuwabara S, Kiernan MC, Macaskill P, Vucic S.

Clin Neurophysiol. 2016 Jul;127(7):2684-91. doi: 10.1016/j.clinph.2016.04.005. Epub 2016 Apr 16.

PMID:
27212114
19.

Prevalence of elevated alanine transaminase in Australia and its relationship to metabolic risk factors: A cross-sectional study of 9,447 people.

Mahady SE, Gale J, Macaskill P, Craig JC, George J.

J Gastroenterol Hepatol. 2017 Jan;32(1):169-176. doi: 10.1111/jgh.13434.

PMID:
27144984
20.

Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.

Jacklyn G, Glasziou P, Macaskill P, Barratt A.

Br J Cancer. 2016 May 24;114(11):1269-76. doi: 10.1038/bjc.2016.90. Epub 2016 Apr 28.

Supplemental Content

Loading ...
Support Center